We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SGH:ASXSGH Limited Analysis

Data as of 2026-07-21 - not real-time

A$44.32

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading near its short‑term moving average, which currently aligns with the long‑term average, indicating a flat price trajectory. Momentum indicators show the RSI just above the neutral midpoint, while the MACD histogram sits in negative territory, hinting at modest bearish pressure. Volume has been on a downtrend, suggesting diminishing trader participation and a potential slowdown in price moves. The beta reading is low, pointing to reduced sensitivity to broader market swings, yet the recent volatility is elevated, implying price swings can still be sizable. Analyst consensus leans toward a buy, with median price targets positioned above the current level, offering modest upside.
Valuation metrics are on the higher side, with a trailing price‑earnings multiple well above market averages and a price‑to‑book ratio indicating premium pricing. However, the forward price‑earnings estimate is considerably lower, suggesting that earnings expectations may improve and bring valuation closer to fairness. The market sentiment index is in the extreme greed zone, reflecting bullish investor mood that could support price gains in the near term. Support sits just below the current price, while resistance is a few ticks higher, creating a relatively tight trading range. Given the lack of dividend payouts, income‑focused investors have limited appeal, but growth‑oriented participants may find the upside potential attractive.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price hovering near short‑term support
  • negative MACD histogram indicating bearish momentum
  • low beta reducing market‑wide risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • forward PE suggesting improving earnings outlook
  • analyst price targets above current levels
  • moderate upside potential within a tight range

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • growth orientation despite premium valuation
  • low beta and stable geographic exposure
  • sustained bullish sentiment reflected in market mood index

Key Metrics & Analysis

Financial Health

P/E Ratio41.8
P/B Ratio3.5

Technical Analysis

TrendNeutral
RSI53.9
SupportA$43.20
ResistanceA$47.24
MA 20A$44.66
MA 50A$42.76
MA 200A$44.66
MACDBearish
VolumeDecreasing
Fear & Greed Index89.75

Valuation

Target PriceA$49.58
Upside/Downside11.87%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.48
Volatility27.99%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.